pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Rituxan · news · pharmadog
← back to Rituxan
News mentioning Rituxan
24
stories
1d
Caribou layoffs could wipe out 90% of staff
biospace
3d
Genmab and AbbVie’s Epkinly win, a rush of deals, Sarepta’s turnaround hopes, more
biospace
4d
AbbVie, Genmab's Epkinly sets ‘new standard of care’ in first-line lymphoma in Phase 3
biospace
12d
‘We’re so close to the tech companies’: Genentech CEO talks Fierce through vision for the future
fiercebiotech
16d
China’s Henlius carves out $440M T-cell engager deal with Amberstone
fiercebiotech
22d
Ultragenyx prices Sanfilippo gene therapy at $4M; Bristol Myers shelves Orum drug
biopharma dive
Jun 30, 26
Ipsen’s $450M blood cancer drug; FDA selects first cohort for “pre-check” pilot program
biopharma dive
Jun 4, 26
An ADC specialist sinks on safety concerns for blood cancer drug
biopharma dive
Jun 4, 26
A Spanish biotech banks $87M to make differentiated ADCs
biopharma dive
May 12, 26
Dr McCann on the FDA Approval of Vepdegestrant for ESR1-Mutated, ER+ Advanced Breast Cancer
onclive
May 12, 26
Honesty and Humor Provide Hope in Breast Cancer Survivorship: With Sara Nunnery, MD, MSCI; and Annie Bond
onclive
May 12, 26
Dr Postow on an Ideal Post-ICI Monitoring Framework in Melanoma
onclive
May 12, 26
Dr Postow on the Timing of Delayed or Re-Emergent irAEs in Melanoma
onclive
May 12, 26
Temple Health’s Fox Chase Cancer Center and Labcorp Collaborate to Test Ultra-Sensitive Blood-Based Assay for Early-Stage Lung Cancer Recurrence Risk
onclive
May 12, 26
GU Cancer Experts Highlight Top Abstracts to Watch During ASCO 2026
onclive
May 12, 26
Unmet Needs in Endometrial Cancer
onclive
May 12, 26
EGFR-Mutated NSCLC: Mechanism and Clinical Role of TROP2-Directed ADCs
onclive
May 12, 26
Future Directions in Relapsed and Refractory Multiple Myeloma
onclive
May 12, 26
Dr Parikh on the Feasibility and Importance of Immunotherapy Trials in Anal Cancer
onclive
May 12, 26
Sequencing Strategies After Progression in Multiple Myeloma
onclive
May 12, 26
EGFR-Mutated NSCLC: Targeting MET-Driven Resistance in Second-Line Therapy
onclive
May 12, 26
Sequencing ADCs in Endometrial Cancer
onclive
May 12, 26
Second Clinical Scenario - Progressive Disease Despite Hematocrit Control
onclive
May 11, 26
Real-World Data Highlight Survival Benefit of Rituximab Maintenance After Frontline BR in MCL
onclive
